Adlai Nortye Ltd. Sponsored ADR

ANL Healthcare Biotechnology

Adlai Nortye Ltd. Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $5.0 million, roughly unchanged from fiscal 2023. Dividend growth for five consecutive years.

11.07 1.02 −8.44%
Market cap
$710.1M
P/E
—
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
−22.05
Beneish M
n/a
Dividend safety
n/a
Jun '26 Dec '25 Jun '25 Dec '24 Older periods
ROE
0.00% 0.00% 0.00% —

+3 more TTM periods

ROA
0.00% 0.00% 0.00% —
ROIC
0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets
0.00% 0.00% 0.00% 0.00%
Average Days of Receivables
0.00 — — —
Free Cash Flow per Share
0.00 0.00 0.00 0.00
Free Cash Flow
(115.75) (129.37) (151.96) (155.67)
Other line items

Show all line items

Columns are period end dates